{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:08:43Z","timestamp":1783631323429,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T00:00:00Z","timestamp":1463788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T00:00:00Z","timestamp":1463788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50AT006268"],"award-info":[{"award-number":["P50AT006268"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-09-1-0689"],"award-info":[{"award-number":["W81XWH-09-1-0689"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s10585-016-9792-z","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T02:04:52Z","timestamp":1464055492000},"page":"475-485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells"],"prefix":"10.1007","volume":"33","author":[{"given":"Wendan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashvini","family":"Belosay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula T.","family":"Iwaniec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell T.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona I.","family":"Churchwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Doerge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2697-7066","authenticated-orcid":false,"given":"William G.","family":"Helferich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,21]]},"reference":[{"issue":"2","key":"9792_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ijc.10941","volume":"104","author":"TN Mitropoulou","year":"2003","unstructured":"Mitropoulou TN, Tzanakakis GN, Kletsas D, Kalofonos HP, Karamanos NK (2003) Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells. Int J Cancer 104(2):155\u2013160","journal-title":"Int J Cancer"},{"issue":"12","key":"9792_CR2","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3945\/jn.109.111864","volume":"139","author":"EJ Kim","year":"2009","unstructured":"Kim EJ, Shin M, Park H, Hong JE, Shin HK, Kim J et al (2009) Oral administration of 3,3\u2032-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB\/c mice. J Nutr 139(12):2373\u20132379","journal-title":"J Nutr"},{"issue":"3","key":"9792_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/jso.2930230311","volume":"23","author":"YT Lee","year":"1983","unstructured":"Lee YT (1983) Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol 23(3):175\u2013180","journal-title":"J Surg Oncol"},{"issue":"5","key":"9792_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.cell.2013.08.020","volume":"154","author":"T Guise","year":"2013","unstructured":"Guise T (2013) Breast cancer bone metastases: it\u2019s all about the neighborhood. Cell 154(5):957\u2013959","journal-title":"Cell"},{"issue":"17","key":"9792_CR5","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1158\/1078-0432.CCR-11-3310","volume":"18","author":"M Martin","year":"2012","unstructured":"Martin M, Bell R, Bourgeois H, Brufsky A, Diel I, Eniu A et al (2012) Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid. Clin Cancer Res 18(17):4841\u20134849","journal-title":"Clin Cancer Res"},{"issue":"4","key":"9792_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12672-013-0145-y","volume":"4","author":"RJ Santen","year":"2013","unstructured":"Santen RJ, Yue W, Heitjan DF (2013) Occult breast tumor reservoir: biological properties and clinical significance. Horm Cancer 4(4):195\u2013207","journal-title":"Horm Cancer"},{"issue":"9","key":"9792_CR7","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/ijc.28224","volume":"133","author":"YC Chen","year":"2013","unstructured":"Chen YC, Prabhu KS, Das A, Mastro AM (2013) Dietary selenium supplementation modifies breast tumor growth and metastasis. Int J Cancer 133(9):2054\u20132064","journal-title":"Int J Cancer"},{"issue":"7","key":"9792_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1023\/A:1011953118186","volume":"18","author":"AM Tester","year":"2000","unstructured":"Tester AM, Ruangpanit N, Anderson RL, Thompson EW (2000) MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits. Clin Exp Metastasis 18(7):553\u2013560","journal-title":"Clin Exp Metastasis"},{"issue":"8","key":"9792_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMoa050434","volume":"353","author":"S Braun","year":"2005","unstructured":"Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC et al (2005) A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353(8):793\u2013802","journal-title":"N Engl J Med"},{"issue":"4","key":"9792_CR10","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/jcb.21148","volume":"101","author":"IJ Fidler","year":"2007","unstructured":"Fidler IJ, Kim S, Langley RR (2007) The role of the organ microenvironment in the biology and therapy of cancer metastasis. J Cell Biochem 101(4):927\u2013936","journal-title":"J Cell Biochem"},{"issue":"3","key":"9792_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1039\/C0MB00145G","volume":"7","author":"G Nassa","year":"2011","unstructured":"Nassa G, Tarallo R, Guzzi PH, Ferraro L, Cirillo F, Ravo M et al (2011) Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells. Mol BioSyst 7(3):667\u2013676","journal-title":"Mol BioSyst"},{"issue":"3\u20135","key":"9792_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0960-0760(03)00358-3","volume":"86","author":"R Luthra","year":"2003","unstructured":"Luthra R, Kirma N, Jones J, Tekmal RR (2003) Use of letrozole as a chemopreventive agent in aromatase overexpressing transgenic mice. J Steroid Biochem Mol Biol 86(3\u20135):461\u2013467","journal-title":"J Steroid Biochem Mol Biol"},{"key":"9792_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1749-6632.2008.03689.x","volume":"1155","author":"LF Macedo","year":"2009","unstructured":"Macedo LF, Sabnis G, Brodie A (2009) Aromatase inhibitors and breast cancer. Ann N Y Acad Sci 1155:162\u2013173","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"9792_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1634\/theoncologist.9-2-126","volume":"9","author":"SM Campos","year":"2004","unstructured":"Campos SM (2004) Aromatase inhibitors for breast cancer in postmenopausal women. Oncologist 9(2):126\u2013136","journal-title":"Oncologist"},{"issue":"Suppl 1","key":"9792_CR15","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/S0960-9776(08)70004-3","volume":"17","author":"CI Herold","year":"2008","unstructured":"Herold CI, Blackwell KL (2008) The impact of adjuvant endocrine therapy on reducing the risk of distant metastases in hormone-responsive breast cancer. Breast 17(Suppl 1):S15\u2013S24","journal-title":"Breast"},{"issue":"2","key":"9792_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.critrevonc.2010.01.006","volume":"77","author":"F Puglisi","year":"2010","unstructured":"Puglisi F, Minisini AM (2010) Adjuvant endocrine therapy in postmenopausal breast cancer patients: does hormone receptor status influence decision-making? Crit Rev Oncol Hematol 77(2):87\u201399","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"9792_CR17","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.ctrv.2007.07.014","volume":"33","author":"L Del Mastro","year":"2007","unstructured":"Del Mastro L, Clavarezza M, Venturini M (2007) Reducing the risk of distant metastases in breast cancer patients: role of aromatase inhibitors. Cancer Treat Rev 33(8):681\u2013687","journal-title":"Cancer Treat Rev"},{"issue":"Supplement 2","key":"9792_CR18","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1016\/j.breast.2013.07.035","volume":"22","author":"JN Ingle","year":"2013","unstructured":"Ingle JN (2013) Postmenopausal women with hormone receptor-positive breast cancer: balancing benefit and toxicity from aromatase inhibitors. Breast 22(Supplement 2):S180\u2013S183","journal-title":"Breast"},{"issue":"2","key":"9792_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3816\/CBC.2006.n.021","volume":"7","author":"BA Mincey","year":"2006","unstructured":"Mincey BA, Duh MS, Thomas SK, Moyneur E, Marynchencko M, Boyce SP et al (2006) Risk of cancer treatment\u2014associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors. Clin Breast Cancer 7(2):127\u2013132","journal-title":"Clin Breast Cancer"},{"issue":"9","key":"9792_CR20","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.22618","volume":"109","author":"KR Bauer","year":"2007","unstructured":"Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype. Cancer 109(9):1721\u20131728","journal-title":"Cancer"},{"issue":"1\u20135","key":"9792_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jsbmb.2006.09.025","volume":"102","author":"PB Gupta","year":"2006","unstructured":"Gupta PB, Kuperwasser C (2006) Contributions of estrogen to ER-negative breast tumor growth. J Steroid Biochem Mol Biol 102(1\u20135):71\u201378","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"9792_CR22","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1158\/0008-5472.CAN-06-3895","volume":"67","author":"PB Gupta","year":"2007","unstructured":"Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA et al (2007) Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res 67(5):2062\u20132071","journal-title":"Cancer Res"},{"issue":"6","key":"9792_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10585-012-9559-0","volume":"30","author":"X Yang","year":"2013","unstructured":"Yang X, Belosay A, Du M, Fan TM, Turner RT, Iwaniec UT et al (2013) Estradiol increases ER-negative breast cancer metastasis in an experimental model. Clin Exp Metastasis 30(6):711\u2013721","journal-title":"Clin Exp Metastasis"},{"issue":"5","key":"9792_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/IJN.S8488","volume":"7","author":"S You","year":"2010","unstructured":"You S, Zuo L, Li W (2010) Optimizing the time of Doxil injection to increase the drug retention in transplanted murine mammary tumors. Int J Nanomed 7(5):221\u2013229","journal-title":"Int J Nanomed"},{"issue":"1","key":"9792_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/carcin\/bgu237","volume":"36","author":"SA Dabydeen","year":"2015","unstructured":"Dabydeen SA, Kang K, Diaz-Cruz ES, Alamri A, Axelrod ML, Bouker KB et al (2015) Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance. Carcinogenesis 36(1):122\u2013132","journal-title":"Carcinogenesis"},{"issue":"5","key":"9792_CR26","doi-asserted-by":"publisher","first-page":"R132","DOI":"10.1186\/bcr3330","volume":"14","author":"LA Martin","year":"2012","unstructured":"Martin LA, Pancholi S, Farmer I, Guest S, Ribas R, Weigel MT et al (2012) Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo. Breast Cancer Res 14(5):R132","journal-title":"Breast Cancer Res"},{"issue":"7","key":"9792_CR27","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2967\/jnumed.112.103465","volume":"53","author":"AM Fowler","year":"2012","unstructured":"Fowler AM, Chan SR, Sharp TL, Fettig NM, Zhou D, Dence CS et al (2012) Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer. J Nucl Med 53(7):1119\u20131126","journal-title":"J Nucl Med"},{"issue":"1\u20135","key":"9792_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jsbmb.2007.05.010","volume":"106","author":"A Brodie","year":"2007","unstructured":"Brodie A, Sabnis G, Macedo L (2007) Xenograft models for aromatase inhibitor studies. J Steroid Biochem Mol Biol 106(1\u20135):119\u2013124","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3 Suppl","key":"9792_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/cncr.23191","volume":"112","author":"LF Macedo","year":"2008","unstructured":"Macedo LF, Sabnis G, Brodie A (2008) Preclinical modeling of endocrine response and resistance: focus on aromatase inhibitors. Cancer 112(3 Suppl):679\u2013688","journal-title":"Cancer"},{"issue":"21","key":"9792_CR30","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.1158\/1078-0432.CCR-04-0565","volume":"10","author":"D Jelovac","year":"2004","unstructured":"Jelovac D, Macedo L, Handratta V, Long BJ, Goloubeva OG, Ingle JN et al (2004) Effects of exemestane and tamoxifen in a postmenopausal breast cancer model. Clin Cancer Res 10(21):7375\u20137381","journal-title":"Clin Cancer Res"},{"issue":"12","key":"9792_CR31","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1158\/0008-5472.CAN-04-2782","volume":"65","author":"D Jelovac","year":"2005","unstructured":"Jelovac D, Macedo L, Goloubeva OG, Handratta V, Brodie AM (2005) Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model. Cancer Res 65(12):5439\u20135444","journal-title":"Cancer Res"},{"issue":"2","key":"9792_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/carcin\/bgg198","volume":"25","author":"CD Allred","year":"2004","unstructured":"Allred CD, Allred KF, Ju YH, Clausen LM, Doerge DR, Schantz SL et al (2004) Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis 25(2):211\u2013218","journal-title":"Carcinogenesis"},{"issue":"1","key":"9792_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/toxsci\/kfu021","volume":"139","author":"MI Churchwell","year":"2014","unstructured":"Churchwell MI, Camacho L, Vanlandingham MM, Twaddle NC, Sepehr E, Delclos KB et al (2014) Comparison of life-stage-dependent internal dosimetry for bisphenol A, ethinyl estradiol, a reference estrogen, and endogenous estradiol to test an estrogenic mode of action in sprague dawley rats. Toxicol Sci 139(1):4-20","journal-title":"Toxicol Sci"},{"issue":"8 Pt 1","key":"9792_CR34","first-page":"2726","volume":"37","author":"MJ Filardi","year":"1977","unstructured":"Filardi MJ, Lininger L, McKneally MF (1977) Adaptation of an automatic bacterial colony counter for measuring lung tumor growth in mice. Cancer Res 37(8 Pt 1):2726\u20132728","journal-title":"Cancer Res"},{"issue":"6","key":"9792_CR35","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/cncr.2820360918","volume":"36","author":"H Wexler","year":"1975","unstructured":"Wexler H, Chretien PB, Ketcham AS, Sindelar WF (1975) Induction of pulmonary metastases in both immune and nonimmune mice. Effect of the removal of a transplanted primary tumor. Cancer 36(6):2042\u20132047","journal-title":"Cancer"},{"issue":"1","key":"9792_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10549-008-0135-x","volume":"117","author":"A Lucci","year":"2009","unstructured":"Lucci A, Krishnamurthy S, Singh B, Bedrosian I, Meric-Bernstam F, Reuben J et al (2009) Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow. Breast Cancer Res Treat 117(1):61\u201368","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"9792_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ (2003) The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer 3(6):453\u2013458","journal-title":"Nat Rev Cancer"},{"issue":"3 Suppl","key":"9792_CR38","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/cncr.11132","volume":"97","author":"SM Kakonen","year":"2003","unstructured":"Kakonen SM, Mundy GR (2003) Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer 97(3 Suppl):834\u2013839","journal-title":"Cancer"},{"issue":"7","key":"9792_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1023\/A:1020958915361","volume":"19","author":"BO Murphy","year":"2002","unstructured":"Murphy BO, Joshi S, Kessinger A, Reed E, Sharp JG (2002) A murine model of bone marrow micrometastasis in breast cancer. Clin Exp Metastasis 19(7):561\u2013569","journal-title":"Clin Exp Metastasis"},{"issue":"12","key":"9792_CR40","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1172\/JCI0215234","volume":"109","author":"RS Muraoka","year":"2002","unstructured":"Muraoka RS, Dumont N, Ritter CA, Dugger TC, Brantley DM, Chen J et al (2002) Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J Clin Investig 109(12):1551\u20131559","journal-title":"J Clin Investig"},{"issue":"7","key":"9792_CR41","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ctrv.2012.02.007","volume":"38","author":"C Wilson","year":"2012","unstructured":"Wilson C, Holen I, Coleman RE (2012) Seed, soil and secreted hormones: potential interactions of breast cancer cells with their endocrine\/paracrine microenvironment and implications for treatment with bisphosphonates. Cancer Treat Rev 38(7):877\u2013889","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"9792_CR42","doi-asserted-by":"publisher","first-page":"H663","DOI":"10.1152\/ajpheart.00337.2011","volume":"301","author":"PE de Almeida","year":"2011","unstructured":"de Almeida PE, van Rappard JRM, Wu JC (2011) In vivo bioluminescence for tracking cell fate and function. Am J Physiol Heart Circ Physiol 301(3):H663\u2013H671","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"9792_CR43","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1227\/01.NEU.0000367452.37534.B1","volume":"66","author":"A Sun","year":"2010","unstructured":"Sun A, Hou L, Prugpichailers T, Dunkel J, Kalani MA, Chen X et al (2010) Firefly luciferase-based dynamic bioluminescence imaging: a noninvasive technique to assess tumor angiogenesis. Neurosurgery 66(4):751\u2013757 (discussion 757)","journal-title":"Neurosurgery"},{"issue":"7","key":"9792_CR44","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1158\/0008-5472.CAN-05-4416","volume":"66","author":"CL Banka","year":"2006","unstructured":"Banka CL, Lund CV, Nguyen MTN, Pakchoian AJ, Mueller BM, Eliceiri BP (2006) Estrogen induces lung metastasis through a host compartment-specific response. Cancer Res 66(7):3667\u20133672","journal-title":"Cancer Res"},{"issue":"1","key":"9792_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10549-009-0714-5","volume":"124","author":"MA Bonelli","year":"2010","unstructured":"Bonelli MA, Fumarola C, Alfieri RR, La Monica S, Cavazzoni A, Galetti M et al (2010) Synergistic activity of letrozole and sorafenib on breast cancer cells. Breast Cancer Res Treat 124(1):79\u201388","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"9792_CR46","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/sj.bjc.6605579","volume":"102","author":"HL Neville-Webbe","year":"2010","unstructured":"Neville-Webbe HL, Coleman RE, Holen I (2010) Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction. Br J Cancer 102(6):1010\u20131017","journal-title":"Br J Cancer"},{"issue":"5","key":"9792_CR47","doi-asserted-by":"publisher","first-page":"618","DOI":"10.7150\/ijbs.11380","volume":"11","author":"G Ma","year":"2015","unstructured":"Ma G, He J, Yu Y, Xu Y, Yu X, Martinez J et al (2015) Tamoxifen inhibits ER-negative breast cancer cell invasion and metastasis by accelerating Twist1 degradation. Int J Biol Sci 11(5):618\u2013628","journal-title":"Int J Biol Sci"},{"issue":"6","key":"9792_CR48","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/carcin\/bgi370","volume":"27","author":"YH Ju","year":"2006","unstructured":"Ju YH, Allred KF, Allred CD, Helferich WG (2006) Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations. Carcinogenesis 27(6):1292\u20131299","journal-title":"Carcinogenesis"},{"issue":"11","key":"9792_CR49","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1093\/carcin\/bgn161","volume":"29","author":"YH Ju","year":"2008","unstructured":"Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG (2008) Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis 29(11):2162\u20132168","journal-title":"Carcinogenesis"},{"issue":"4","key":"9792_CR50","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/carcin\/bgi320","volume":"27","author":"YH Ju","year":"2006","unstructured":"Ju YH, Fultz J, Allred KF, Doerge DR, Helferich WG (2006) Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis 27(4):856\u2013863","journal-title":"Carcinogenesis"},{"issue":"1","key":"9792_CR51","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1359\/jbmr.2002.17.1.172","volume":"17","author":"HM Heshmati","year":"2002","unstructured":"Heshmati HM, Khosla S, Robins SP, O\u2019Fallon WM, Melton LJ, Riggs BL (2002) Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res 17(1):172\u2013178","journal-title":"J Bone Miner Res"},{"issue":"4","key":"9792_CR52","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10585-015-9709-2","volume":"32","author":"X Yang","year":"2015","unstructured":"Yang X, Belosay A, Hartman JA, Song H, Zhang Y, Wang W et al (2015) Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors. Clin Exp Metastasis 32(4):323\u2013333","journal-title":"Clin Exp Metastasis"},{"key":"9792_CR53","volume-title":"Mouse 4T1 breast tumor model. Current protocols in immunology","author":"BA Pulaski","year":"2001","unstructured":"Pulaski BA, Ostrand-Rosenberg S (2001) Mouse 4T1 breast tumor model. Current protocols in immunology. Wiley, New York"},{"key":"9792_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/1471-2407-8-228","volume":"8","author":"K Tao","year":"2008","unstructured":"Tao K, Fang M, Alroy J, Sahagian GG (2008) Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 8:228","journal-title":"BMC Cancer"},{"issue":"1","key":"9792_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1155\/JBB.2005.10","volume":"2005","author":"JM Xanthopoulos","year":"2005","unstructured":"Xanthopoulos JM, Romano AE, Majumdar SK (2005) Response of mouse breast cancer cells to anastrozole, tamoxifen, and the combination. J Biomed Biotechnol 2005(1):10\u201319","journal-title":"J Biomed Biotechnol"},{"issue":"3","key":"9792_CR56","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1023\/A:1019905111666","volume":"75","author":"T Michigami","year":"2002","unstructured":"Michigami T, Hiraga T, Williams PJ, Niewolna M, Nishimura R, Mundy GR et al (2002) The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs. Breast Cancer Res Treat 75(3):249\u2013258","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"9792_CR57","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1158\/0008-5472.CAN-11-3287","volume":"72","author":"V Iyer","year":"2012","unstructured":"Iyer V, Klebba I, McCready J, Arendt LM, Betancur-Boissel M, Wu MF et al (2012) Estrogen promotes ER-negative tumor growth and angiogenesis through mobilization of bone marrow-derived monocytes. Cancer Res 72(11):2705\u20132713","journal-title":"Cancer Res"},{"key":"9792_CR58","doi-asserted-by":"crossref","unstructured":"Roy S, Chakravarty D, Cortez V, Mukhopadhyay KD, Bandyopadhyay A, Ahn JM et al. (2011) Significance of PELP1 in ER-negative breast cancer metastasis. Mol Cancer Res","DOI":"10.1158\/1541-7786.MCR-11-0456"},{"issue":"1","key":"9792_CR59","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/1535-7163.MCT-11-0548","volume":"11","author":"S Zhang","year":"2012","unstructured":"Zhang S, Kim K, Jin UH, Pfent C, Cao H, Amendt B et al (2012) Aryl Hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells. Mol Cancer Ther 11(1):108\u2013118","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"9792_CR60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/bcr2645","volume":"12","author":"L Hoefnagel","year":"2010","unstructured":"Hoefnagel L, van de Vijver MJ, van Slooten H, Wesseling P, Wesseling J, Westenend P et al (2010) Receptor conversion in distant breast cancer metastases. Breast Cancer Res 12(5):75","journal-title":"Breast Cancer Res"},{"issue":"3","key":"9792_CR61","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/01.RES.81.3.355","volume":"81","author":"AN MacRitchie","year":"1997","unstructured":"MacRitchie AN, Jun SS, Chen Z, German Z, Yuhanna IS, Sherman TS et al (1997) Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 81(3):355\u2013362","journal-title":"Circ Res"},{"issue":"3","key":"9792_CR62","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1210\/er.2004-0027","volume":"26","author":"KF Koehler","year":"2005","unstructured":"Koehler KF, Helguero LA, Haldos\u00e9n L, Warner M, Gustafsson J (2005) Reflections on the discovery and significance of estrogen receptor \u00df. Endocr Rev 26(3):465\u2013478","journal-title":"Endocr Rev"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-016-9792-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-016-9792-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-016-9792-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-016-9792-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T23:03:21Z","timestamp":1589411001000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-016-9792-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,21]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["9792"],"URL":"https:\/\/doi.org\/10.1007\/s10585-016-9792-z","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,21]]},"assertion":[{"value":"22 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}